Skip to main content
Telix Pharmaceuticals Limited (TLX)
Telix Pharmaceuticals was planning to go public, but the IPO was withdrawn on Jun 14, 2024.
IPO Price
$11.87
Shares Offered
17,000,000
Deal Size
$201.79M

Telix Pharmaceuticals Cash Flow Statement

Millions AUD. Fiscal year is Jan - Dec.
Year
 20232022
Net Income
5.21-104.08
Other Operating Activities
18.6740.11
Operating Cash Flow
23.88-63.97
Acquisitions
--0.97
Change in Investments
-14.7-2.16
Other Investing Activities
-10.79-13.86
Investing Cash Flow
-25.49-17
Dividends Paid
-10.79-13.86
Share Issuance / Repurchase
6.65181.04
Debt Issued / Paid
3.531.74
Other Financing Activities
10.796.05
Financing Cash Flow
10.19174.96
Net Cash Flow
8.5893.99
Free Cash Flow
13.09-77.83
Free Cash Flow Margin
2.60%-48.62%
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).